Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma.

Creed JH, Peeri NC, Anic GM, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA, Brockman JD, Gerke TA, Nabors LB, Egan KM.

Sci Rep. 2019 Jul 26;9(1):10861. doi: 10.1038/s41598-019-47284-4.

2.

Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida.

Reblin M, Sahebjam S, Peeri NC, Martinez YC, Thompson Z, Egan KM.

J Palliat Med. 2019 Oct;22(10):1202-1207. doi: 10.1089/jpm.2018.0528. Epub 2019 May 13.

PMID:
31081711
3.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.

Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.

4.

Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma.

Peeri NC, Creed JH, Anic GM, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA, Brockman JD, Gerke TA, Nabors LB, Egan KM.

Cancer Epidemiol. 2018 Aug;55:45-51. doi: 10.1016/j.canep.2018.05.002. Epub 2018 May 25.

PMID:
29777993
5.

Handedness and the risk of glioma.

Miller B, Peeri NC, Nabors LB, Creed JH, Thompson ZJ, Rozmeski CM, LaRocca RV, Chowdhary S, Olson JJ, Thompson RC, Egan KM.

J Neurooncol. 2018 May;137(3):639-644. doi: 10.1007/s11060-018-2759-y. Epub 2018 Jan 13.

Supplemental Content

Loading ...
Support Center